DrShivani Misra
Clinical Associate Professor in Diabetes
Department of Metabolism, Digestion and Reproduction - Faculty of Medicine
Orcid identifier0000-0003-2886-0726 (opens in a new tab)
- Clinical Associate Professor in DiabetesDepartment of Metabolism, Digestion and Reproduction - Faculty of Medicine
- Commonwealth Building, Hammersmith Campus, United Kingdom
BIO
Shivani is a Clinical Associate Professor, Honorary Consultant Physician in Diabetes and is Head of Section for Metabolic Medicine within the Faculty of Medicine at Imperial College London.
Dr Misra’s research team aims to enhance diabetes care by harnessing diversity observed across different ancestry groups to better tailor treatment and prevention to those living with and at risk of type 2 diabetes & type 1 diabetes.
The core focus is on early-onset type 2 diabetes (a diagnosis in youth and adults <40 years), which is characterised by 10-20 years of reduced life expectancy. The research group has 3 main areas of focus 1) Big data analysis of early-onset type 2 diabetes ethnic differences; 2) observational cohort studies analysing diabetes classification and genetic variation across ethnic groups and 3) physiological studies examining differences in beta-cell function and ectopic fat.
The groups analyses of the National Diabetes Audit (NDA) provided the first nationwide estimates of early-onset type 2 diabetes in England, revealing its disproportionate burden in younger adults and marked inequalities across ethnicity, and deprivation. Her research group is funded through grants from the Wellcome Trust, Novo Nordisk Foundation, Medical Research Council, Diabetes UK, NIHR and Breakthrough T1D.
Dr Misra serves as Clinical Advisor to the NHS England T2DAY programme, which has allocated £14 million to improve care for individuals diagnosed with early-onset type 2 diabetes in England (under 40 years old). She is also Chair of the Young Type 2 Diabetes Audit Group, which utilises real-world data from the entire English diabetes population to drive policy changes and service improvements.
In 2023 Dr Misra was awarded the Precision Medicine in Diabetes Prize from the European Study for the Association of Diabetes and Novo Nordisk Foundation and she currently serves as Co-Chair of the Precision Medicine in Diabetes Consortium and serve on the council of the NIDDK (NIH) Heterogeneity of Diabetes global coalition.
Dr Misra’s research team aims to enhance diabetes care by harnessing diversity observed across different ancestry groups to better tailor treatment and prevention to those living with and at risk of type 2 diabetes & type 1 diabetes.
The core focus is on early-onset type 2 diabetes (a diagnosis in youth and adults <40 years), which is characterised by 10-20 years of reduced life expectancy. The research group has 3 main areas of focus 1) Big data analysis of early-onset type 2 diabetes ethnic differences; 2) observational cohort studies analysing diabetes classification and genetic variation across ethnic groups and 3) physiological studies examining differences in beta-cell function and ectopic fat.
The groups analyses of the National Diabetes Audit (NDA) provided the first nationwide estimates of early-onset type 2 diabetes in England, revealing its disproportionate burden in younger adults and marked inequalities across ethnicity, and deprivation. Her research group is funded through grants from the Wellcome Trust, Novo Nordisk Foundation, Medical Research Council, Diabetes UK, NIHR and Breakthrough T1D.
Dr Misra serves as Clinical Advisor to the NHS England T2DAY programme, which has allocated £14 million to improve care for individuals diagnosed with early-onset type 2 diabetes in England (under 40 years old). She is also Chair of the Young Type 2 Diabetes Audit Group, which utilises real-world data from the entire English diabetes population to drive policy changes and service improvements.
In 2023 Dr Misra was awarded the Precision Medicine in Diabetes Prize from the European Study for the Association of Diabetes and Novo Nordisk Foundation and she currently serves as Co-Chair of the Precision Medicine in Diabetes Consortium and serve on the council of the NIDDK (NIH) Heterogeneity of Diabetes global coalition.
FACULTY
- Faculty of Medicine
POSITION NAME
- Clinical Associate Professor in Diabetes